Related Experiment Video
Updated: Aug 16, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Cardiopulmonary bypass in pregnancy: possible new role for the intra-aortic balloon pump
Timothy W Willcox1, Peter Stone, F Paget Milsom
1Cardiothoracic Surgical Unit, Green Lane Hospital, Green Lane West, Auckland, New Zealand. timw@adhb.govt.nz
Cardiopulmonary bypass (CPB) during pregnancy is associated with a maternal mortality similar to the nonpregnant population; however, fetal morbidity and mortality are high. Various strategies to improve fetal survival have been advocated. Alteration in uterine artery flow velocity has been reported during nonpulsatile CPB; however, roller pump-generated pulsatile flow for CPB remains controversial. We report use of the intra-aortic balloon pump (IABP) in two cases of pregnancy. In the first, the IABP was inserted after termination of a long bypass, specifically in an attempt to improve uterine perfusion and thereby relieve a profound fetal bradycardia. In the second, the IABP was used electively to provide pulsatile flow during the bypass period primarily to benefit fetal hemodynamics.
Cardiopulmonary bypass (CPB) during pregnancy is associated with a maternal mortality similar to the nonpregnant population; however, fetal morbidity and mortality are high. Various strategies to improve fetal survival have been advocated. Alteration in uterine artery flow velocity has been reported during nonpulsatile CPB; however, roller pump-generated pulsatile flow for CPB remains controversial. We report use of the intra-aortic balloon pump (IABP) in two cases of pregnancy. In the first, the IABP was inserted after termination of a long bypass, specifically in an attempt to improve uterine perfusion and thereby relieve a profound fetal bradycardia. In the second, the IABP was used electively to provide pulsatile flow during the bypass period primarily to benefit fetal hemodynamics.
